Skip to Content

3137 WPI (Nizatidine 150 mg)

Pill with imprint 3137 WPI is White, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of erosive esophagitis; gerd; duodenal ulcer prophylaxis; duodenal ulcer; indigestion (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3137 WPI

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide